Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Neoplasm in the Central Nervous System”

454 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 454 results

Not applicableLooking for participantsNCT02754544
What this trial is testing

Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Who this might be right for
Brain NeoplasmMetastatic Malignant Neoplasm in the BrainRecurrent Brain Neoplasm
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT03631407
What this trial is testing

Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)

Who this might be right for
Colorectal Neoplasms
Merck Sharp & Dohme LLC 41
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Large-scale testing (Phase 3)Active Not RecruitingNCT00950001
What this trial is testing

Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center 132
Not applicableStudy completedNCT02250755
What this trial is testing

MRI Perfusion on T1 and T2 Brain Lesion(s)

Who this might be right for
Lung Carcinoma Metastatic to the Brain
University Hospital, Lille 30
Early research (Phase 1)Looking for participantsNCT06650163
What this trial is testing

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Who this might be right for
GliomaMalignant Brain NeoplasmMeningioma+1 more
Jonsson Comprehensive Cancer Center 20
Not applicableUnknownNCT02607605
What this trial is testing

A Prospective, Observational Trial on the Diagnostic and Prognostic of LM

Who this might be right for
Lung NeoplasmsMeningeal Carcinomatosis
Sun Yat-sen University 10
Early research (Phase 1)Ended earlyNCT05831995
What this trial is testing

Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.

Who this might be right for
Advanced Solid TumorRAS MutationRAF Mutation+1 more
ABM Therapeutics Corporation 12
Not applicableEnded earlyNCT02580045
What this trial is testing

Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer

Who this might be right for
Metastatic Cancer Patients on an Anti-cancer TherapyAdvanced CancerBrain Metastasis
Duke University 3
Testing effectiveness (Phase 2)Ended earlyNCT01497665
What this trial is testing

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
Angiochem Inc 16
Early research (Phase 1)Active Not RecruitingNCT03696030
What this trial is testing

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Who this might be right for
Malignant NeoplasmMetastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the Leptomeninges+2 more
City of Hope Medical Center 24
Early research (Phase 1)Study completedNCT00025311
What this trial is testing

Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health
Early research (Phase 1)Ended earlyNCT05241613
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 28
Testing effectiveness (Phase 2)WithdrawnNCT05567055
What this trial is testing

Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET Alterations

Who this might be right for
Non-small Cell Lung Cancer
Timothy Burns, MD, PHD
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Not applicableUnknownNCT03257735
What this trial is testing

The Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases

Who this might be right for
Lung CancerBrain MetastasesCerebrospinal Fluid+1 more
Sun Yat-sen University 50
Large-scale testing (Phase 3)Study completedNCT00030628
What this trial is testing

Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Cancer
Alliance for Clinical Trials in Oncology 480
Not applicableLooking for participantsNCT04988009
What this trial is testing

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Who this might be right for
Central Nervous System NeoplasmLeptomeningeal NeoplasmMetastatic Malignant Neoplasm in the Brain+1 more
M.D. Anderson Cancer Center 200
Not applicableActive Not RecruitingNCT07448493
What this trial is testing

Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer

Who this might be right for
Gastric CancerEsophageal CancerBrain Metastases
Blokhin's Russian Cancer Research Center 230
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Load More Results